Search
for
Sort by
Research 61–90 of 160
- <i>Retraction of:</i> Bansal and Arora. J Endourol. Epub ahead of print; DOI: 10.1089/end.2016.0696
- Diagnosis and treatment of prostatitis after TURP
- 1726: Risk Decrease of Intra-Operative Bleeding During TURP with the Uptake of Finasteride: Evaluation of VEGF and CD34
- Current treatment of BPH
- Finasteride as a Neo-Adjuvant Treatment for TURPLiterature Review
- Lower Urinary Tract Symptoms in Men
- Clinical Analysis of Parkinson's Disease with Urinary Bladder Dysfunction:A Report of 64 Cases
- Key Clinical Trials in BPH
- Postoperative Urinary Retention is an Independent Predictor of Short-Term and Long-Term Future Bladder Outlet Procedure in Men
- UP-02.011 Biofeedback Treatment for Dysfunctional Voiding Diagnosed in Adulthood
- Acute urinary retention: risks and management.
- CLINICAL OBSERVATION: HYPONATREMIA ASSOCIATED WITH DIURETIC USE AND URINARY RETENTION IN AN OLDER MAN
- The role of dutasteride in the treatment of benign prostatic obstruction and related conditions
- Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia.
- Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors
- Bladder cancer survival in men using 5-alpha-reductase inhibitors
- Efficacy and safety of α-blockers plus 5α-reductase inhibitors for benign prostatic hyperplasia: a systematic review and meta-analysis
- The Effect of Finasteride on the Expression of Vascular Endothelial Growth Factor and Microvessel Density: A Possible Mechanism for Decreased Prostatic Bleeding in Treated Patients
- Clinical Pearls in Men's Health
- Clinics in diagnostic imaging (221)
- Polypoid Cystitis and Bilateral Hydronephrosis Mimicking Urothelial Carcinoma
- Neoadjuvant therapy with Disitamab vedotin in treating muscle-invasive bladder cancer: A case report
- #6180 OXALATE NEPHROPATHY SECONDARY TO ENTERIC HYPEROXALURIA: A RARE CAUSE OF END STAGE RENAL FAILURE – A REPORT OF 2 CASES
- 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- What do we know about phytotherapy of benign prostatic hyperplasia?
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- RE: CHRONIC TREATMENT WITH FINASTERIDE DAILY DOES NOT AFFECT SPERMATOGENESIS OR SEMEN PRODUCTION IN YOUNG MEN
- Endocrine treatment of benign prostatichypertrophy: Current concepts